| 注册
首页|期刊导航|中医药临床杂志|胡顺金分期分型辨治IgA肾病经验

胡顺金分期分型辨治IgA肾病经验

刘润楠 胡顺金 王乐

中医药临床杂志2025,Vol.37Issue(9):1725-1729,5.
中医药临床杂志2025,Vol.37Issue(9):1725-1729,5.DOI:10.16448/j.cjtcm.2025.0909

胡顺金分期分型辨治IgA肾病经验

HU Shunjin's Experience in Treating IgA Nephropathy by Stages and Types

刘润楠 1胡顺金 2王乐1

作者信息

  • 1. 安徽中医药大学研究生院 安徽 合肥 230012
  • 2. 安徽中医药大学第一附属医院,安徽省中医院 安徽 合肥 230031
  • 折叠

摘要

Abstract

IgA nephropathy(IgAN),as a common primary glomerular disease,progresses to end-stage renal disease in approximately 40%of patients.Current treatments with glucocorticoids and immunosuppressive agents show questionable efficacy and significant side effects,highlighting the multi-target therapeutic advantages of traditional Chinese medicine(TCM).Based on over 35 years of clinical experience by Chief Physician Hu Shunjin,a renowned TCM expert,he identifies the kidney as the primary affected organ in IgAN,which can also involve the spleen,lung,and other organs.He defines the core pathogenesis as"deficiency in origin and excess in manifestation"(chronic phase primarily featuring deficiency of lung,spleen,and kidney;acute phase dominated by external pathogenic excess)and establishes a staging-classification system(Chronic Sustained Phase:lung-kidney qi deficiency pattern,qi-yin deficiency pattern,spleen-kidney deficiency pattern;Acute Episode Phase:wind-heat invading lung pattern,damp-heat internal accumulation pattern).Analysis of five typical medical cases confirms the significant efficacy of stage-specific and pattern-based medication,providing guidance for the precise staging and pattern differentiation in the clinical treatment of IgAN.

关键词

胡顺金/名中医/IgA肾病/经验

Key words

HU Shunjin/Renowned Chinese medicine practitioner/IgA nephropathy/Experience

分类

医药卫生

引用本文复制引用

刘润楠,胡顺金,王乐..胡顺金分期分型辨治IgA肾病经验[J].中医药临床杂志,2025,37(9):1725-1729,5.

基金项目

胡顺金省名中医工作室项目 ()

2021年安徽省医疗卫生重点专科建设项目(皖卫函[2021]273号) (皖卫函[2021]273号)

中医药临床杂志

1672-7134

访问量0
|
下载量0
段落导航相关论文